Panbela Announces Closing of Approximately $15 Million Public Offering, and Regains Compliance with Nasdaq Listing Standards Feb 13, 2023 08:30AM
Panbela Therapeutics Inc. (PBLA) Prices Approximately $15 Million Public Offering of Common Stock, Warrants Jan 26, 2023 08:42AM
Panbela Announces Pricing of Approximately $15 Million Public Offering Jan 26, 2023 08:41AM
Panbela Announces Pricing of Approximately $15 Million Public Offering Jan 26, 2023 08:41AM
Maxim Group Downgrades Panbella Therapeutics (PBLA) to Hold Oct 12, 2022 08:02AM


Sep 30, 2022 08:38AM Panbela Therapeutics Inc. (PBLA) Prices Approximately $6 Million Public Offering
Sep 30, 2022 08:37AM Panbela Announces Pricing of Approximately $6 Million Public Offering
Sep 30, 2022 08:37AM Panbela Announces Pricing of Approximately $6 Million Public Offering
Mar 23, 2022 08:30AM Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28, 202
Mar 23, 2022 08:30AM Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28, 202